Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein

Details for Australian Patent Application No. 2004304767 (hide)

International Classifications

Event Publications

10 November 2005 Amendment Made

The nature of the amendment is: Add priority details 10/414,539 14 Apr 2003 US 2004314005 Samsung Electronics Co., Ltd. The nature of the amendment is: Amend the name of the applicant from Samsung Electronics Co., Ltd.? to Samsung Electronics Co., Ltd. 2005

10 November 2005 PCT application entered the National Phase

PCT publication WO2005/060375 Priority application(s): WO2005/060375

2 April 2009 Assignment before Grant

Nuvelo, Inc. The application has been assigned to ARCA biopharma, Inc. 2005

11 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.